
Federal regulations prescribe distinct protections for children participating in research zzso zzso for collecting tissue specimens from children solely for research purposes must pose no more than a minor increase over minimum risk, thereby limiting the zzso zzso zzso studies to evaluate zzso targeted agents in children with zzso Ethical issues arise when zzso zzso studies are a mandatory component of an zzso pediatric clinical trial of new zzso zzso The National Cancer Institute Cancer zzso zzso Program sponsored a workshop in 2002 to discuss tissue collection for zzso zzso studies in zzso childhood cancer clinical studies of zzso targeted zzso Workshop participants recommended the zzso zzso tissue specimens for zzso studies should provide vital clinical and scientific results to qualify for zzso pediatric study zzso zzso parents should receive a realistic appraisal of the risks, requirements, and potential for benefit of phase I protocol zzso zzso investigators should clearly distinguish clinically necessary procedures from research procedures of no benefit to the child to improve zzso study informed zzso and zzso participation in zzso research studies included in clinical trials generally should be zzso The need to acquire important zzso data regarding new molecular agents will challenge the ingenuity of pediatric cancer researchers, zzso the application of highly sensitive laboratory zzso methods, new imaging procedures, and zzso models of childhood zzso Such innovative methods can allow necessary scientific information to be obtained while simultaneously respecting the protections appropriately afforded to children participating in research studies and minimizing the burden of research participation for children with cancer and their zzso 

